IOL Chemicals and Pharmaceuticals Limited (BOM:524164)
India · Delayed Price · Currency is INR 169.55
+5.75 (3.51%)
At close: Aug 21, 2026
BOM:524164 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,376 | 1,011 | 1,344 | 1,391 | 1,677 |
Depreciation & Amortization | 802.3 | 719.9 | 619.2 | 460.5 | 431.3 |
Other Amortization | - | - | 9.9 | 1.1 | 1.3 |
Loss (Gain) From Sale of Assets | 3 | 1 | -1.4 | 3.3 | 2.4 |
Asset Writedown & Restructuring Costs | 4.6 | 0.8 | 0.4 | 2.6 | 8.5 |
Loss (Gain) From Sale of Investments | -2.3 | -4.3 | -3.3 | -0.1 | -0.2 |
Other Operating Activities | 131.4 | 266.8 | 25.4 | 0.8 | -166.1 |
Change in Accounts Receivable | -734.6 | -390.4 | 276.6 | -430.7 | -1,708 |
Change in Inventory | -104.5 | 642.2 | -993.2 | 843.7 | -1,148 |
Change in Accounts Payable | 666.9 | -460.5 | 1,620 | -1,050 | 1,832 |
Operating Cash Flow | 2,143 | 1,786 | 2,898 | 1,223 | 930.5 |
Operating Cash Flow Growth | 19.99% | -38.36% | 137.00% | 31.40% | -75.50% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -1,730 | -2,136 | -2,742 | -2,118 | -1,533 |
Sale of Property, Plant & Equipment | 20.9 | 9.8 | 18.5 | 22.2 | 18.9 |
Investment in Securities | -393.2 | 459.1 | 677.7 | 802.3 | 224.1 |
Other Investing Activities | 121.1 | 124.8 | 135.7 | 93.7 | 84.7 |
Investing Cash Flow | -1,981 | -1,542 | -1,910 | -1,200 | -1,205 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 149.6 | 842.8 | - | 368.8 | 427.5 |
Total Debt Issued | 149.6 | 842.8 | - | 368.8 | 427.5 |
Short-Term Debt Repaid | - | - | -468.7 | - | - |
Long-Term Debt Repaid | -1.1 | - | -1.8 | -10.9 | -10.6 |
Total Debt Repaid | -1.1 | - | -470.5 | -10.9 | -10.6 |
Net Debt Issued (Repaid) | 148.5 | 842.8 | -470.5 | 357.9 | 416.9 |
Common Dividends Paid | -293.5 | -234.8 | -293.5 | -235 | -352.2 |
Other Financing Activities | -145.3 | -147.6 | -161 | -164 | -81.1 |
Financing Cash Flow | -290.3 | 460.4 | -925 | -41.1 | -16.4 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -128.2 | 704.8 | 63 | -18.4 | -291.1 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 413.3 | -349.3 | 156.1 | -895.5 | -602.4 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | 1.78% | -1.68% | 0.73% | -4.04% | -2.76% |
Free Cash Flow Per Share | 1.41 | -1.19 | 0.53 | -3.05 | -2.05 |
Levered Free Cash Flow | -15.5 | -656.01 | -376.8 | -936.19 | -719.14 |
Unlevered Free Cash Flow | 46.94 | -594.14 | -309.05 | -869.38 | -703.95 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 145.3 | 147.6 | 161 | 164 | 81.1 |
Cash Income Tax Paid | 378.6 | 183.2 | 420.2 | 471 | 625.8 |
Change in Working Capital | -172.2 | -208.7 | 903.3 | -636.9 | -1,023 |